中新集團(601512.SH)擬參與投資元生創投三期人民幣基金 佔比不超10%
格隆匯9月22日丨中新集團(601512.SH)公佈,公司擬作為有限合夥人參與投資由蘇州工業園區元福創業投資管理企業(有限合夥)(以下簡稱“元福創投”)發起設立的元生創投三期人民幣基金,並以現金貨幣方式向元生創投三期人民幣基金出資不超過1億元且佔比不超過10%,資金來源為公司自有資金。元生創投三期人民幣基金採用有限合夥形式設立,規模不低於人民幣10億元且不超過人民幣25億元。
其中,公司擬認繳出資不超過基金認繳出資總額的10%且不超過1億元,中方財團認繳出資5000萬元、新建元控股認繳出資2億元、生物公司認繳出資1億元,其他有限合夥人認繳出資不低於5.3億元、不超過20.25億元。
基金主要投資於藥物研發/生產企業、診斷技術/醫療器械企業、醫療服務外包企業、納米材料企業等生物醫藥企業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.